HIV Treatment Failure: Testing for HIV Resistance in Clinical Practice
- 19 June 1998
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 280 (5371), 1871-1873
- https://doi.org/10.1126/science.280.5371.1871
Abstract
Perrin and Talenti discuss how to evaluate antiretroviral therapy for AIDS. Their examination of data from the Swiss HIV cohort study suggest that failure or success is more complicated than analysis of virus replication. These observations have an impact on discussions of the relevance of HIV resistance testing to clinical practice.Keywords
This publication has 16 references indexed in Scilit:
- Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp.Journal of Antimicrobial Chemotherapy, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)The Lancet, 1998
- Failure Isn't What It Used to Be ... But Neither Is SuccessScience, 1998
- Getting to the HAART of T cell dynamicsNature Medicine, 1998
- Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patientsAIDS, 1997
- Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavirAIDS, 1997
- Antiretroviral Therapy for HIV Infection in 1997JAMA, 1997
- Transmission of Human Immunodeficiency Virus Type 1 Resistant to Nevirapine and ZidovudineThe Journal of Infectious Diseases, 1997
- Extensive polymorphisms observed in HIV–1 clade B protease gene using high–density oligonucleotide arraysNature Medicine, 1996